Zhejiang Zhebei Pharmaceutical

Zhejiang Zhebei Pharmaceutical Co., Ltd., established in 1989 and headquartered in Deqing County, Zhejiang Province, is a professional pharmaceutical manufacturer specializing in nucleoside antiviral and cardiovascular drugs. The company operates as a high-tech enterprise with an integrated production chain encompassing active pharmaceutical ingredients (APIs) and finished preparations, including tablets, oral liquids, and injections. Its core product portfolio features widely used medications such as acyclovir, ribavirin, cetirizine hydrochloride, and sodium fructose diphosphate. With multiple manufacturing bases and a strong focus on the generic drug market, the company serves both domestic and international markets, including Southeast Asia and India. Zhejiang Zhebei Pharmaceutical is recognized for its GMP-compliant facilities and its role as a key player in the regional pharmaceutical industry.